Any molecule that provides information about one's health can be a biomarker, including DNA, proteins, and hormones. They can be grouped according to a number of criteria, including characteristics like imaging biomarkers or molecular biomarkers. Over the course of the forecast period, an increase in R&D projects aimed at enhancing the efficacy of biomarker-based tests and assays is anticipated to fuel market expansion.
The Global Biomarkers Market is estimated to be valued at US$ 55.59 Bn in 2022 and is expected to exhibit a CAGR of 13.6% over the forecast period (2022-2030).
Major Players in the Biomarkers Industry:
1. Agilent Technologies, Inc.
Agilent Technologies, Inc. was founded in 19999 and it’s headquarter in Santa Clara, California, United States.The Company operates in 100+ countries. In 2020 announced the launch of the Biomarker Pathologist Training Program,
2. F. Hoffmann-La Roche Ltd.,
F. Hoffmann-La Roche Ltd., was launch in 1896. And its headquarter located in Basel, Switzerland. It work in more than 110 country in world.In 2021 F. Hoffmann-La Roche Ltd. (Switzerland) launched Elecsys Anti-p53 immunoassay to aid the diagnosis of various types of cancers